Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Sarah H, Kim"'
Autor:
Sarah H Kim, Britta Weigelt
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101431- (2024)
Cell-free DNA (cfDNA) analysis has several promising clinical applications in the management of cancer patients, with clinical validity established in different types of solid tumors (e.g., lung, breast, and colon cancer). Cancers harbor unique genet
Externí odkaz:
https://doaj.org/article/34d19e6eb59c437a80abf1eb9fe39866
Publikováno v:
Gynecologic Oncology Reports, Vol 53, Iss , Pp 101415- (2024)
Background: Uterine leiomyomas are benign tumors characterized by pelvic pain and abnormal bleeding. Their evolution can lead to degenerative changes, occasionally mimicking malignancies on imaging, presenting diagnostic challenges. Case presentation
Externí odkaz:
https://doaj.org/article/a6e4a232db11470698182a877e2e0a06
Autor:
Daniel H. Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, Sarah H. Kim, Ashley F. Haggerty, Nawar Latif, Lori Cory, Robert L. Giuntoli, Mark A. Morgan, Lilie L. Lin, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100922- (2022)
Objectives: To examine overall survival (OS) and cancer-specific survival (CSS) for different racial groups of women with surgically staged endometrial cancer by histologic subtype. Methods: This is a retrospective cohort study of women with stage I-
Externí odkaz:
https://doaj.org/article/9b56877f403f46559c5972e8eef9533b
Autor:
Sarah H. Kim, Arnaud Da Cruz Paula, Thais Basili, Higinio Dopeso, Rui Bi, Fresia Pareja, Edaise M. da Silva, Rodrigo Gularte-Mérida, Zhen Sun, Sho Fujisawa, Caitlin G. Smith, Lorenzo Ferrando, Ana Paula Martins Sebastião, Yonina Bykov, Anqi Li, Catarina Silveira, Charles W. Ashley, Anthe Stylianou, Pier Selenica, Wesley R. Samore, Achim A. Jungbluth, Dmitriy Zamarin, Nadeem R. Abu-Rustum, Kristian Helin, Robert A. Soslow, Jorge S. Reis-Filho, Esther Oliva, Britta Weigelt
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Little is known about the genetics of sclerosing stromal tumor of the ovary, a rare type of sex cord-stromal tumor. Here, the authors use sequencing strategies to show that in a cohort of 26 tumor samples 65% carry a FHL2-GLI2 fusion gene and demonst
Externí odkaz:
https://doaj.org/article/47b2a974b2b14385a7cca2142adfd91e
Autor:
Dimitrios, Nasioudis, Nawar A, Latif, Emily M, Ko, Lori, Cory, Sarah H, Kim, Fiona, Simpkins, Mark A, Morgan, Robert L, Giuntoli
Publikováno v:
Gynecologic Oncology. 169:41-46
Investigate outcomes for advanced stage epithelial ovarian cancer (EOC) patients based on facility-level utilization of neoadjuvant chemotherapy (NACT).Stage III-IV EOC patients diagnosed between 2010 and 2016 were identified in the National Cancer D
Autor:
Dimitrios, Nasioudis, Neil K, Taunk, Emily M, Ko, Ashley F, Haggerty, Lori, Cory, Robert L, Giuntoli, Sarah H, Kim, Nawar A, Latif
Publikováno v:
American Journal of Clinical Oncology. 45:373-378
Evaluate whether the addition of external beam radiation (EBRT) to adjuvant chemotherapy with or without vaginal brachytherapy is associated with better survival for patients with stage IIIC endometrioid endometrial carcinoma.Patients diagnosed betwe
Autor:
Dimitrios Nasioudis, Spyridon A Mastroyannis, Emily M Ko, Ashley F Haggerty, Lori Cory, Robert L Giuntoli, Sarah H Kim, Nawar A Latif
Publikováno v:
International Journal of Gynecologic Cancer. 32:1355-1360
ObjectiveTo investigate the utilization and outcomes of ovarian preservation for premenopausal patients with International Federation of Gynecology and Obstetrics (FIGO) stage I grade 2 and 3 endometrioid endometrial carcinoma undergoing hysterectomy
Autor:
Beryl L. Manning-Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn, Krysten Soldan, William P. Tew, Nicholas J. Sarlis, Dmitriy Zamarin, Sara Kravetz, Ilaria Laface, Teresa Rasalan-Ho, Jingjing Qi, Phillip Wong, Paul J. Sabbatini, Roisin E. O’Cearbhaill
Publikováno v:
Cancers; Volume 15; Issue 5; Pages: 1458
We examined the safety and immunogenicity of sequential administration of a tetravalent, non-HLA (human leukocyte antigen) restricted, heteroclitic Wilms’ Tumor 1 (WT1) peptide vaccine (galinpepimut-S) with anti–PD-1 (programmed cell death protei
Autor:
Emeline Aviki, Ross S. Berkowitz, Vance Broach, Leigh A. Cantrell, M. Herman Chui, William Cliby, Kevin M. Elias, Lora Hedrick Ellenson, Amanda N. Fader, Donato Callegaro Filho, Nicole D. Fleming, Michael Frumovitz, David M. Gershenson, Sushmita Gordhandas, Rachel N. Grisham, Arthur Herbst, R. Tyler Hillman, Emily Hinchcliff, Anjelica Hodgson, Neil S. Horowitz, Elizabeth Kertowidjojo, Sarah H. Kim, Anne Knisely, Katherine C. Kurnit, Barrett Lawson, Mario M. Leitao, Douglas A. Levine, Ying Liu, Beverly Long, Beryl Manning-Geist, Diana Miao, Jennifer J. Mueller, Priyadharsini Nagarajan, Roisin E. O’Cearbhaill, Katherine Peng, Preetha Ramalingam, Ravin Ratan, Gloria Salvo, Alessandro D. Santin, Aaron Shafer, Pamela Soliman, Sahana Somasegar, Joan R. Tymon-Rosario, Jason D. Wright, S. Diane Yamada, Oliver Zivanovic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e91131e1134b764aa5bbe23c84c326e
https://doi.org/10.1016/b978-0-323-82938-0.09993-6
https://doi.org/10.1016/b978-0-323-82938-0.09993-6